BioPartner Nordic ApS: Financial statements 2021
CVR: 38153188
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
BioPartner Nordic ApS (CVR 38153188) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 121,400 and a net result of DKK -10,713 compared with DKK 55,766 the year before. That is a decrease of 49.5% compared with the year before. The profit margin was -8.8%. Equity in the 2021 report amounted to DKK 5,425. The solvency ratio was 1.7%.
- Revenue
- DKK 121,400
- Gross Profit
- DKK 23,410
- Profit/Loss
- DKK -10,713
- Equity
- DKK 5,425
- Total Assets
- DKK 326,875
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 121K | 23K | -11K | 5K | - |
| 2020 | 240K | 78K | 56K | -62K | - |
| 2019 | 58K | -137K | -167K | -118K | - |
| 2018 | 587K | 185K | 185K | 50K | - |
Official annual report
Find more companies like BioPartner Nordic ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
BioPartner Nordic ApS has published its annual report for 2020. Revenue came to DKK 240,490, and the net result was DKK 55,766.
About BioPartner Nordic ApS
BioPartner Nordic ApS is a Danish company of the type Anpartsselskab based in Hedehusene, founded in 2016. The company is registered under the industry Anden teknisk rådgivning. The management consists of John Holger Schultz. The company is owned by John Holger Schultz. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -7,778 and a net result of DKK -27,378 compared with DKK -79,721 the year before. Equity in the 2025 report amounted to DKK 22,622.
